U.S. Pharmaceutical Sales - Q2 2011
The following is a list of the top 100 prescribed medicines by US National Sales in Q2 2011. Figures include sales through both retail and hospital channels, listed by drug name and units sold in the United States.
Last updated: February 2014 (updated quarterly).
Top 100 drugs for Q2 2011 by units sold
Rank |
Drug |
Units (000) |
|
|
1 ( ) |
acetaminophen/hydrocodone Generic |
9,592 |
n/a |
Stats |
2 ( 1) |
Nexium AstraZeneca |
7,476 |
-0.77% |
Stats |
3 ( 3) |
Singulair Merck |
7,442 |
6.34% |
Stats |
4 ( 2) |
budesonide Generic |
7,220 |
-29.37% |
Stats |
5 |
OneTouch
|
7,145 |
0.45% |
Stats |
6 ( 2) |
ProAir HFA Teva Pharmaceuticals USA, Inc. |
7,070 |
-2.92% |
Stats |
7 |
Lipitor
|
6,492 |
1.93% |
Stats |
8 |
Advair Diskus GlaxoSmithKline |
6,094 |
-2.93% |
Stats |
9 |
Lantus Sanofi |
6,056 |
-2.51% |
Stats |
10 |
Cymbalta
|
5,949 |
4.46% |
Stats |
11 |
Plavix
|
5,459 |
-0.18% |
Stats |
12 |
fentanyl Generic |
4,569 |
4.58% |
Stats |
13 ( 12) |
AndroGel AbbVie Inc. |
4,504 |
93.39% |
Stats |
14 ( 1) |
Crestor AstraZeneca |
3,915 |
3.35% |
Stats |
15 |
Spiriva Boehringer Ingelheim Pharmaceuticals, Inc. |
3,219 |
2.29% |
Stats |
16 ( 1) |
venlafaxine Generic |
3,137 |
6.48% |
Stats |
17 ( 3) |
Actos Takeda Pharmaceutical Company Limited |
3,109 |
-4.89% |
Stats |
18 ( 1) |
Lantus Solostar Sanofi |
3,068 |
8.30% |
Stats |
19 ( 3) |
Novolog Novo Nordisk |
2,966 |
-0.70% |
Stats |
20 ( 2) |
Nasonex Merck |
2,954 |
0.75% |
Stats |
21 ( 1) |
Humalog Eli Lilly and Company |
2,647 |
1.15% |
Stats |
22 |
Abilify Otsuka Pharmaceutical Co., Ltd |
2,564 |
0.98% |
Stats |
23 ( ) |
Synthroid AbbVie Inc. |
2,544 |
n/a |
Stats |
24 ( 1) |
metoprolol Generic |
2,526 |
4.38% |
Stats |
25 ( 11) |
Levemir Novo Nordisk |
2,316 |
23.65% |
Stats |
26 ( 2) |
Lexapro
|
2,314 |
-0.94% |
Stats |
27 ( 1) |
Diovan Novartis Pharmaceuticals Corporation |
2,298 |
-1.03% |
Stats |
28 ( 1) |
valacyclovir Generic |
2,248 |
5.84% |
Stats |
29 ( 1) |
Combivent Boehringer Ingelheim Pharmaceuticals, Inc. |
2,108 |
-2.86% |
Stats |
30 |
Namenda
|
2,073 |
-0.86% |
Stats |
31 |
Lyrica
|
2,050 |
0.74% |
Stats |
32 ( 1) |
Januvia Merck |
2,028 |
3.89% |
Stats |
33 ( 1) |
Zetia Merck |
2,027 |
-0.10% |
Stats |
34 |
bupropion Generic |
2,025 |
4.60% |
Stats |
35 ( 9) |
NovoLog FlexPen Novo Nordisk |
1,953 |
29.60% |
Stats |
36 ( 1) |
Seroquel AstraZeneca |
1,832 |
-0.54% |
Stats |
37 ( 2) |
Flovent HFA GlaxoSmithKline |
1,826 |
-4.60% |
Stats |
38 ( 1) |
donepezil Generic |
1,804 |
3.50% |
Stats |
39 ( 1) |
Suboxone
|
1,736 |
4.08% |
Stats |
40 ( 2) |
Lovaza GlaxoSmithKline |
1,715 |
4.00% |
Stats |
41 ( 3) |
Vytorin Merck |
1,698 |
-7.52% |
Stats |
42 ( 1) |
Benicar Daiichi Sankyo |
1,606 |
-2.96% |
Stats |
43 |
Lidoderm Endo Pharmaceuticals Inc. |
1,599 |
-0.19% |
Stats |
44 ( 5) |
Remicade Janssen Pharmaceuticals, Inc. |
1,552 |
7.11% |
Stats |
45 ( 6) |
enoxaparin Generic |
1,518 |
10.80% |
Stats |
46 |
Symbicort AstraZeneca |
1,486 |
0.41% |
Stats |
47 ( 2) |
Zyprexa
|
1,473 |
-1.14% |
Stats |
48 ( 1) |
Diovan HCT Novartis Pharmaceuticals Corporation |
1,431 |
-2.12% |
Stats |
49 ( 1) |
OxyContin Purdue Pharma LP |
1,365 |
-1.02% |
Stats |
50 ( 2) |
Restasis Allergan plc |
1,297 |
0.23% |
Stats |
51 ( 2) |
Niaspan AbbVie Inc. |
1,262 |
-1.02% |
Stats |
52 ( 4) |
Lovenox Sanofi |
1,233 |
-15.37% |
Stats |
53 ( 2) |
Celebrex
|
1,064 |
2.01% |
Stats |
54 ( 2) |
TriCor AbbVie Inc. |
1,003 |
-1.86% |
Stats |
55 ( 2) |
Evista
|
965 |
-3.50% |
Stats |
56 ( ) |
VESIcare Astellas Pharma US, Inc. |
952 |
n/a |
Stats |
57 ( 1) |
Aciphex Eisai Inc. |
947 |
-4.63% |
Stats |
58 ( 2) |
Enbrel Amgen Inc. |
874 |
3.19% |
Stats |
59 |
Detrol LA Viatris |
857 |
-7.65% |
Stats |
60 ( 1) |
Janumet Merck |
855 |
3.14% |
Stats |
61 ( 2) |
Epogen Amgen Inc. |
793 |
4.48% |
Stats |
62 ( 2) |
Geodon
|
739 |
-0.27% |
Stats |
63 ( 2) |
Vyvanse Takeda Pharmaceutical Company Limited |
661 |
-1.49% |
Stats |
64 ( 3) |
Rebif EMD Serono, Inc. |
605 |
-0.66% |
Stats |
65 ( 3) |
amphetamine/dextroamphetamine Generic |
577 |
7.25% |
Stats |
66 ( 3) |
Cialis Eli Lilly and Company |
547 |
2.43% |
Stats |
67 ( 5) |
Rituxan Genentech, Inc. |
537 |
5.09% |
Stats |
68 ( 2) |
Truvada Gilead Sciences, Inc. |
534 |
1.71% |
Stats |
69 ( 2) |
Humira AbbVie Inc. |
532 |
2.31% |
Stats |
70 ( 10) |
Provigil
|
516 |
34.73% |
Stats |
71 ( 9) |
Concerta Janssen Pharmaceuticals, Inc. |
489 |
-37.94% |
Stats |
72 ( 2) |
Avastin Genentech, Inc. |
471 |
-0.63% |
Stats |
73 |
Viagra
|
467 |
-2.30% |
Stats |
74 ( 2) |
Seroquel XR AstraZeneca |
459 |
3.85% |
Stats |
75 |
Atripla Gilead Sciences, Inc. |
456 |
1.79% |
Stats |
76 ( 1) |
Adderall XR Takeda Pharmaceutical Company Limited |
437 |
2.58% |
Stats |
77 ( ) |
methylphenidate Generic |
421 |
n/a |
Stats |
78 ( 4) |
Procrit Janssen Pharmaceuticals, Inc. |
380 |
5.56% |
Stats |
79 |
Lunesta Sunovion Pharmaceuticals Inc. |
377 |
-2.58% |
Stats |
80 ( 1) |
Aranesp Amgen Inc. |
372 |
-1.33% |
Stats |
81 ( 15) |
Levaquin Janssen Pharmaceuticals, Inc. |
361 |
-42.24% |
Stats |
82 ( 2) |
Neulasta Amgen Inc. |
334 |
3.41% |
Stats |
83 ( ) |
Varivax Merck |
292 |
n/a |
Stats |
84 ( 1) |
Reyataz Bristol-Myers Squibb Company |
285 |
1.79% |
Stats |
85 ( 1) |
Solodyn Medicis Pharmaceutical Corporation |
267 |
-2.20% |
Stats |
86 ( ) |
docetaxel Generic |
266 |
n/a |
Stats |
87 ( 1) |
Erbitux Eli Lilly and Company |
259 |
-0.38% |
Stats |
88 ( 3) |
Lucentis Genentech, Inc. |
230 |
1.32% |
Stats |
89 ( 1) |
Copaxone Teva Pharmaceuticals USA, Inc. |
228 |
n/a |
Stats |
90 ( 3) |
Isentress Merck |
219 |
7.88% |
Stats |
91 ( 1) |
Zometa Novartis Pharmaceuticals Corporation |
209 |
-6.70% |
Stats |
92 ( ) |
Eloxatin Sanofi |
182 |
n/a |
Stats |
93 ( 2) |
Alimta Eli Lilly and Company |
170 |
4.29% |
Stats |
94 ( 2) |
Neupogen Amgen Inc. |
157 |
0.64% |
Stats |
95 ( 1) |
Zyvox Pfizer Inc. |
155 |
-6.06% |
Stats |
96 ( 1) |
Herceptin Genentech, Inc. |
149 |
1.36% |
Stats |
97 ( 1) |
Avonex Biogen Inc. |
140 |
-1.41% |
Stats |
98 ( ) |
Velcade Takeda Pharmaceutical Company Limited |
134 |
n/a |
Stats |
99 ( 1) |
Gleevec Novartis Pharmaceuticals Corporation |
85 |
1.19% |
Stats |
100 ( 1) |
Betaseron Bayer HealthCare Pharmaceuticals Inc. |
81 |
-7.95% |
Stats |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.